CSPAN3 FDA Transparency - Panel 2 - Investors January 17, 2018
Investors. During this portion of the event we hear from jonathan left, chair of the deerfield institute. Its 25 minutes. Thank you so much for coming. Chairman of the deerfield institute, he joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served...